Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.

Darcy KM, Brady WE, Blancato JK, Dickson RB, Hoskins WJ, McGuire WP, Birrer MJ. Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study. Gynecol Oncol. 2009 Sep; 114(3):472-9.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Chromosomes, Human, Pair 8
Cisplatin
Cyclophosphamide
Female
Gene Amplification
Genes, myc
Humans
In Situ Hybridization, Fluorescence
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Paclitaxel
Treatment Outcome

authors with profiles

Michael Birrer